Recent advances in the management of renal cell carcinoma

by Molina, Ana M., Nanus, David M.
Published 2016

Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib

by Molina, Ana M., Ginsberg, Michelle S., Motzer, Robert J.
Published 2010

Metastatic Non-Clear Cell Renal Cell Carcinoma: An Evidence Based Review of Current Treatment Strategies

by Sankin, Alexander, Hakimi, A. Ari, Hsieh, James J., Molina, Ana M.
Published 2015

Neutrophil Chemokines Secreted by Tumor Cells Mount a Lung Antimetastatic Response during Renal Cell Carcinoma Progression

by López-Lago, Miguel A., Posner, Shai, Thodima, Venkata J., Molina, Ana M., Motzer, Robert J., Chaganti, RSK
Published 2012

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

by Molina, Ana M., Hutson, Thomas E., Larkin, James, Gold, Anne M., Wood, Karen, Carter, Dave, Motzer, Robert, Michaelson, M. Dror
Published 2013

A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma

by Carlo, Maria I., Molina, Ana M., Lakhman, Yulia, Patil, Sujata, Woo, Kaitlin, DeLuca, John, Lee, Chung-Han, Hsieh, James J., Feldman, Darren R., Motzer, Robert J., H. Voss, Martin
Published 2016